![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » StimGuard Receives FDA IDE Designation for Microsize Bladder Device
StimGuard Receives FDA IDE Designation for Microsize Bladder Device
![](https://www.fdanews.com/ext/resources/test/Device_Images4/Blue_syringe.jpg?t=1433878513&width=430)
StimGuard’s wireless microsize Overactive Bladder Syndrome implantable device, capable of being placed completely through a needle, has won an Investigational Device Exemption from the FDA, the devicemaker announced Monday.
Unlike traditional OAB treatment, which requires a large implantable pulse generator, the device does not require a surgical incision. Rather, the product uses the Stimwave electroceutical microchip to administer small energy pulses to electrodes near surrounding nerves.
The device’s treatment therapy, Sacral Nerve Stimulation, has been FDA-approved for severe OAB since 1997.
A clinical trial is scheduled for this summer. More than 33 million people are afflicted with OAB in the U.S. — Jason Scott
Upcoming Events
-
21Oct